Wound dressing composed of hyaluronic acid and collagen containing EGF or bFGF: Comparative culture study

Journal of Biomaterials Science, Polymer Edition

Volumn 24, Issue 8, 2013, Pages 1015-1026

  Yu, Akane ^a   Niiyama, Hayato ^a   Kondo, Shinya ^a   Yamamoto, Akiko ^a   Suzuki, Ryusuke ^a   Kuroyanagi, Yoshimitsu ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Angiogenic factor; bFGF; EGF; Fibroblast; Wound dressing

Indexed keywords

ANGIOGENIC FACTOR; BFGF; CULTURED DERMAL SUBSTITUTES; EGF; EPIDERMAL GROWTH FACTORS; FIBROBLAST PROLIFERATION; VASCULAR ENDOTHELIAL GROWTH FACTOR; WOUND DRESSINGS;

CELL CULTURE; CELL PROLIFERATION; COLLAGEN; FIBROBLASTS; ORGANIC ACIDS;

HYALURONIC ACID;

COLLAGEN SPONGE; HYALURONIC ACID; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT EPIDERMAL GROWTH FACTOR; SCATTER FACTOR; VASCULOTROPIN;

ARTICLE; CELL PROLIFERATION; CROSS LINKING; CULTURE MEDIUM; CYTOKINE PRODUCTION; FIBROBLAST; FREEZE DRYING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; WOUND DRESSING;

BANDAGES; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; HUMANS; HYALURONIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84877974194     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1080/09205063.2012.731375     Document Type: Article

References (25)

1. Lazic T, Falanga V. Bioengineered skin constructs and their use in wound healing. Plast. Reconstr. Surg. 2011;127(Suppl 1): 75S-90S.
2. Metcalfe AD, Ferguson MW. Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J. R. Soc. Interface. 2007;4: 413-437.
3. Singer AJ, Clark RA. Cutaneous wound healing. New England J. Med. 1999;341: 738-746.
4. Moulin V. Growth factors in skin wound healing. Eur. J. Cell Biol. 1995;68: 1-7.
5. Kubo M, Moriguchi T. Attached lysate with Fiblast® spray and benzalkonium chloride were cytotoxic to normal human keratinocytes and fibroblasts cultured on type I collagen. Jpn J. Dermatol. 2011;121: 1607-1620.
6. Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regeneration. 1999;7: 79-89.
7. Laurent TC, Fraser JR. Hyaluronan. FASEB J. 1992;6: 2397-2404.
8. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science. 1985;228: 1324-1326.
9. Sattar A, Rooney P, Kumar S, Pye D, West DC, Scott I, Ledger P. Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J. Invest. Dermatol. 1994;103: 576-579.
10. Lees VC, Fan TP, West DC. Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab. Invest. 1995;73: 259-266.
11. Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc. Natl Acad. Sci. USA. 1978;75: 871-875.
12. Savage CR, Jr, Inagami T, Cohen S. The primary structure of epidermal growth factor. J. Biol. Chem. 1972;247: 7612-7621.
13. Taylor JM, Mitchell WM, Cohen S. Epidermal growth factor. Physical and chemical properties. J. Biol. Chem. 1972;247: 5928-5934.
14. Matsumoto Y, Kuroyanagi Y. Development of a wound dressing composed of hyaluronic acid sponge containing arginine and epidermal growth factor. J. Biomater. Sci. Polym. Ed. 2010;21: 715-726.
15. Kondo S, Kuroyanagi Y. Development of a wound dressing composed of hyaluronic acid and collagen sponge with epidermal growth factor. J. Biomater. Sci. Polym. Ed. 2011;23: 629-643.
16. Kondo S, Niiyama H, Yu A, Kuroyanagi Y. Evaluation of a wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor in diabetic mice. J. Biomater. Sci. Polym. Ed. 2012;23: 1729-1740.
17. Yu A, Matsuda Y, Takeda A, Uchinuma E, Kuroyanagi Y. Effect of EGF and bFGF on fibroblast proliferation and angiogenic cytokine production from cultured dermal substitutes. J. Biomater. Sci. Polym. Ed. 2012;23: 1315-1324.
18. Miyata T, Sode T, Rubin AL, Stenzel KH. Effects of ultraviolet irradiation on native and telopeptide- poor collagen. Biochim. Biophys. Acta. 1971;229: 672-680.
19. Chen SM, Ward SI, Olutoye OO, Diegelmann RF, Kelman Cohen I. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair and Regeneration. 1997;5: 23-32.
20. Wysocki AB. Wound fluids and the pathogenesis of chronic wounds. J. Wound Ostomy Continence Nurs. 1996;23: 283-290.
21. Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl Acad. Sci. USA. 1993;90: 8915-8919.
22. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am. J. Pathol. 1998;152: 1445-1452.
23. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet. 1995;345: 293-295.
24. Toyoda M, Takayama H, Horiguchi N, Otsuka T, Fukusato T, Merlino G, Takagi H, Mori M. Overexpression of hepatocyte growth factor/scatter factor promotes vascularization and granulation tissue formation in vivo. FEBS Lett. 2001;509: 95-100.
25. Xin X, Yang S, Ingle G, Zlot C, Rangell L, Kowalski J, Schwall R, Ferrara N, Gerritsen ME. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am. J. Pathol. 2001;158: 1111-1120.